Ultomiris (Ravulizumab) is a monoclonal antibody. Monoclonal antibodies are man made antibodies that fight antigens (harmful substances) in the body.
Ultomiris injection is used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults.
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired, life threatening disease of the blood characterized by the destruction of red blood cells by the complement system, a part of the body’s innate immune system.
Ultomiris can also be used to treat adults and children 1 month of age and older with a disease called atypical hemolytic uremic syndrome (aHUS). You will need to be vaccinated against meningococcal infections before you start using Ultomiris. Do not breastfeed while using this medicine, and for at least 8 months after your last dose. Some side effects are: headache, nausea, fever, abdominal pain, diarrhea, dizziness or muscle/joint pain.